Australia markets closed

Oncternal Therapeutics, Inc. (ONCT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
8.66-0.17 (-1.93%)
At close: 04:00PM EDT
8.51 -0.44 (-4.93%)
After hours: 04:12PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 26.12M
Enterprise value -630.13k
Trailing P/E 2.11
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.14
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.36
52-week change 342.26%
S&P500 52-week change 326.36%
52-week high 313.20
52-week low 35.57
50-day moving average 38.65
200-day moving average 37.80

Share statistics

Avg vol (3-month) 37.07k
Avg vol (10-day) 34.03k
Shares outstanding 52.96M
Implied shares outstanding 62.96M
Float 82.71M
% held by insiders 19.23%
% held by institutions 115.57%
Shares short (30 Apr 2024) 412.95k
Short ratio (30 Apr 2024) 42.11
Short % of float (30 Apr 2024) 40.45%
Short % of shares outstanding (30 Apr 2024) 40.44%
Shares short (prior month 28 Mar 2024) 416.73k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 310 June 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 308 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,542.88%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.15M
Revenue per share (ttm)0.39
Quarterly revenue growth (yoy)180.30%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-36.38M
Diluted EPS (ttm)-12.33
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)34.26M
Total cash per share (mrq)11.57
Total debt (mrq)318k
Total debt/equity (mrq)1.06%
Current ratio (mrq)N/A
Book value per share (mrq)10.19

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A